SHINE - A Bad Study Of Upfront Ibrutinib + BR is optimal in Mantle Cell | ASCO2022 | I explain why
June 4, 2022
8,787
371
45
4.73%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Vinay Prasad Md Mph Episodes Around June 4, 2022
See what was published immediately before and after this episode.
18:02Now PlayingSHINE - A Bad Study Of Upfront Ibrutinib + BR is optimal in Mantle Cell | ASCO2022 | I explain why
YouTube Description
as posted by the channelVinay Prasad, MD MPH; Physician & Associate Professor
Google Scholar
Personal Website: www.vinayakkprasad.com
Laboratory Website: www.vkprasadlab.com
Podcast Website: www.plenarysessionpodcast.com
Academic Publications
Follow me on:
Twitter @vprasadmdmph
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.